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Background  
Anaplastic thyroid carcinoma (ATC) is a rare, highly
aggressive malignancy with poor prognosis. The role of
surgery remains controversial. Nevertheless there is evi-
dence that a multimodality approach including surgical
resection, radiation, and chemotherapy can ameliorate
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Background. In anaplastic thyroid carcinoma (ATC) surgical re-
section associated to radiotherapy and chemotherapy can ameliorate lo-
cal disease control with occasional long-term survivals.
Patients and methods. Resection of the tumor was accomplished
in 20 ATC patients, with no macroscopic (13 cases) or minimal resi-
dual neck disease infiltrating vital structures (7 cases). Ten of these pa-
tients (50%) had distant metastases. Sixteen cases were also treated
with radiotherapy and chemotherapy, while in one patient only che-
motherapy was possible; 2 patients refused further therapy; the last one
is starting adjuvant treatment. Morbidity and survival were analysed,
and compared with other 15 ATCs submitted to partial tumor de-
bulking or not operated at all (control group).
Results. Function of at least one laryngeal recurrent nerve was pre-
served in all 20 patients; none experienced permanent hypoparathyroi-
dism. At last follow-up examination 17 patients had died and 3 were
alive 1, 6 and 80 months after the operation, the latter being free of di-
sease. Survival of dead patients ranged from 3 to 28 months (mean: 8
months). In the control group all patients died, survival ranging from
1 to 13 months (mean: 4 months). Actuarial analysis of survival
showed a significant difference between the two groups (p = 0.0112);
multivariate analysis of several prognostic factors confirmed that com-
plete or near complete tumour resection was the most relevant.
Conclusions. Surgical resection is an important component of the
multimodal treatment of ATC and should be attempted whenever pos-
sible.
RIASSUNTO: Nostra esperienza nel trattamento chirurgico del car-
cinoma anaplastico della tiroide.
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Introduzione. Nel carcinoma anaplastico della tiroide (ATC)
l’exeresi chirurgica associata a chemio- e radioterapia può migliorare il
controllo locale della malattia con occasionali lunghe sopravvivenze.
Pazienti e metodi. In 20 pazienti con ATC è stato possibile effet-
tuare la resezione del tumore, senza residui macroscopici (13 casi) o con
minimi residui su strutture vitali infiltrate (7 casi); 10 di questi pa-
zienti (50%) avevano già metastasi a distanza. Sedici casi sono stati
trattati anche con chemio- e radioterapia; in uno è stata possibile solo
la chemioterapia; 2 pazienti hanno rifiutato ulteriori terapie; uno sta
per iniziare la terapia adiuvante. Sono state analizzate morbilità e so-
pravvivenza, anche confrontando questi casi con altri 15 ATC sottopo-
sti a exeresi incompleta del tumore cervicale o non operati affatto (grup-
po di controllo).
Risultati. La funzione di almeno un nervo laringeo ricorrente è
stata salvaguardata in tutti i casi, e nessuno ha avuto un ipoparatiroi-
dismo permanente. Al termine dello studio 17 pazienti erano morti e 3
erano vivi a 1, 6 e 80 mesi dall’intervento; quest’ultimo caso è libero da
malattia. La sopravvivenza dei pazienti deceduti varia fra 3 e 28 me-
si (media: 8 mesi). Nel gruppo di controllo tutti i pazienti erano dece-
duti, con sopravvivenze comprese fra 1 e 13 mesi (media: 4 mesi). L’a-
nalisi attuariale della sopravvivenza ha dimostrato una significativa
differenza fra i due gruppi (p = 0.0112); un’analisi multifattoriale di
diversi fattori prognostici ha confermato che il più rilevante era l’exere-
si completa o quasi completa del tumore.
Conclusioni. La resezione chirurgica è una componente impor-
tante del trattamento multimodale dell’ATC e dovrebbe essere tentata
ogniqualvolta possibile.
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local disease control with occasional long-term survivals
(1-4). 
Here, we retrospectively report the results of complete
or near complete surgical resection in a series of ATC pa-
tients treated in a single center of Northern Italy.
Patients and methods
Between 01/01/2003 and 03/31/2010 complete resection of the
tumour was attempted in 22 ATC patients. The study is focused on
20 patients in which the operation was accomplished with no ma-
croscopic, or minimal residual neck disease infiltrating vital struc-
tures. Ten of these patients had distant metastases (TMN stage IV
C: 50%). This was not considered a contraindication, because pri-
mary aim was local disease control. Demoghraphic and clinical data
are set in Table 1. 
Sixteen patients received radiation therapy (36-40 Gy) combi-
ned with chemotherapy (doxorubicin 20 mg/m2 + cis-platinum 20
mg/m2, administered weekly up to a maximum doxorubucin dose
of 550 mg). One patient not suitable for radiotherapy after surgery
was treated by chemotherapy alone (paclitaxel 100 mg/m2 weekly,
for 6 consecutive weeks out of 8 weeks). Two patients refused futher
therapies. One patien has just been operated and is starting adjuvant
treatment.
Operative details and morbidity were analysed. Furthermore, sur-
vival of the 19 patients with a sufficient follow-up was compared with
15 ATCs referred to ours Institutions in the same period, and sub-
mitted to partial tumour debulking or not operated at all (control
group). The follow-up was updated as of February 28, 2010. Cru-
de Kaplan-Meier survival probabilities were estimated, both overall
and stratified by several variables (age at diagnosis, tumour size, TNM
stage, chemotherapy, radiotherapy). Differences between curves were
tested using the two-tailed log-rank test. Multivariate hazard ratios
(HR) and corresponding 95% confidence intervals (95% CI) were
estimated via the Cox proportional hazard model. SAS System v. 8.0
was used.
Results
Operative details 
Relevant operative data are summarized in Table 2.
Two cases required a partial sternotomy for tumour mo-
bilisation and vascular control in the upper mediastinum.
The tumour mass was excised with surrounding infiltrated
tissues and metastatic lymph nodes (Fig. 1). In 4 cases
an internal jugular vein was resected and one patient also
required resection of the vagus nerve, but in most cases
the elements of the vascular bundle were dissected from
the tumour and preserved (Fig. 2). Minimal macrosco-
Fig. 1 - Operative field after complete exeresis: the tumour was “shawed off”
from the trachea and removed with an oval of oesophageal wall; right LRN had
already been paralyzed and was resected.
TABLE 1 - DEMOGRAPHIC AND CLINICAL DATA.
Sex F = 13 (65%)
M = 7
Age 57-88 (mean: 74)
TNM Stage IV A/B = 10 (50%)
IV C = 10
LRN paralysis   7 (35%)
History of multinodular goiter 14 (70%)
− With hyperthyroidism − 4 (20%)
− Submitted to partial resection − 1 (5%)
− Submitted to external beam 
radiotherapy − 1 (5%)
Locoregional recurrence 
of anaplastic cancer 1 (5%)*
* Thyroidectomy for multinodular goiter 3 months before with une-
spected finding of anaplastic cancer
TABLE 2 - OPERATIVE DETAILS.
Access, pts
− Cervicotomy − 18 (90%)
− Cervicotomy plus partial sternotomy − 2
Tumour maximum diameter (cm) 2,5-12,0 (mean: 6,5)
Lymph node metastases 12 (60%)
Deliberate resection of nervous/vascular 
structures, pts 6 (30%)
− RLN − 3 (15%)
− Vagus nerve − 1 (5%)
− Internal jugular vein − 4 (20%)
Macroscopic residual disease 
(R2 resections), pts 7 (35%)
− Infiltrating trachea − 5 (25%)
− Infiltrating pharynx and/or oesophagus − 2 (10%)
− Infiltrating subclavian vein − 1 (5%)
Tracheostomy, pts 1 (5%)
Exeresis of an incidentally discovered 
parathyroid adenoma, pts 1 (5%)
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pic residual disease was left behind in 7 cases (R2 re-
sections: 35%) because an aggressive resection of infil-
trated vital structures was not considered reasonable (5).
The operation ended with a tracheostomy in one case.
Morbidity
Five (25%) monolateral paralyses of the recurrent
laryngeal nerve (RLN) resulted from the deliberate en bloc
resection of one RLN (3 cases) or vagus nerve (one case),
or from the dissection of a RLN encased  by the tumour
(one case). One patient experienced some respiratory di-
stress due to laryngeal edema and bilateral vocal folds hy-
pomobility, that completely recovered after two-days ob-
servation in Intensive Care Unit. No cases of permanent
hypoparathyroidism, or intra-/postoperative haemorrhage
occurred. One patient developed a seroma that resolved
after percutaneous aspiration.
Survival
At last follow-up examination 17 patients had died,
and 3 were alive 1, 6 and 80 months after the operation,
the latter being free of disease. Survival of dead patients
ranged from 3 to 28 months (mean: 8 months); two pa-
tients lived >1 yr and one lived >2 yrs. In the control
group all the patients had died, survival ranging from 1
to 13 months (mean: 4 months).
Crude survival was better in our series than in the con-
trol group (p = 0.0112) and was significantly affected by
any of the other variables. Cox model confirmed that
complete or near complete resection of the tumour was
the most relevant prognostic factor (HR = 0.35; 95% CI:
0.13-0.91) (Fig. 3 and Table 3).
Conclusions
Despite the overall grim outcome of ATC, these re-
sults justify an attempt at complete or near complete re-
section, followed by adjuvant chemoradiotherapy, pos-
sibly in all ATC patients.
Fig. 2 - The elements of right vascular bundle have been dissected from the tu-
mour.
Fig. 3 - Survival in our series and in the control group according to crude Ka-
plan-Meier estimates.
TABLE 3 - KAPLAN-MEIER SURVIVAL ESTIMATES AND
COX MODEL.
Variables % 6 months HR (95% CI)
survival (SE)
Surgical exeresis
− Complete / 
near complete 68.4 (0.11) 0.35 (0.13-0.91)
− Partial / not done 20.0 (0.10) 1
Age at diagnosis
− ≤ 70 46.2 (0.14) 1
− > 70 47.6 (0.11) 1.24 (0.53-2.90)
Tumour diameter (cm)
− ≤ 6.5 47.1 (0.12) 1
− > 6.5 47.1 (0.12) 0.98 (0.38-2.52)
TNM stage
− IV A/B 66.7 (0.12) 1
− IV C 31.6 (0.11) 1.56 (0.64-3.78)
Chemotherapy
− Yes 48.1 (0.10) 0.71 (0.16-3.14)
− Not 42.9 (0.19) 1
Radiotherapy
− Yes 52.4 (0.11) 1.37 (0.33-5.73)
− Not 38.5 (0.13) 1
SE: standard error; HR: hazard ratios; CI: confidence intervals.
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